NOT_YET_RECRUITINGPHASE2

Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

NCT07465198•Biocells Medical

View on ClinicalTrials.gov

Summary

This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group.

Eligibility

Age

35 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Multiple System Atrophy (MSA-P or MSA-C)
•Age range of 35 to 65 years

Exclusion Criteria

•Other major neurological disorders
•Severe cardiac/renal/hepatic impairment
•Prior stem cell therapy

Locations (1)

BioCells Medical

Warsaw, Poland

Key Dates

Start Date

September 1, 2026

Primary Completion Date

September 1, 2029

Completion Date

March 1, 2031

Last Updated

March 11, 2026

Enrollment

50

ESTIMATED participants

Conditions

MSA - Multiple System AtrophyMSA

Interventions

MSCs

DRUG

Placebo

OTHER

Contacts

Andrei Peskau, M.D.

CONTACT

+48660639936 info@biocellsmedical.com

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

NCT06846658

Parkinson DiseaseMSA - Multiple System Atrophy+3 more

View study

RECRUITINGNA

Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing (IMPACT Study)

NCT05792332

Atypical ParkinsonismMSA - Multiple System Atrophy+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 11, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITING